The global Mammography Market size is expected to reach USD 4.67 billion by 2030, registering a CAGR of 10.26% according to a new report by Grand View Research, Inc. The growth is mainly driven by the rising initiatives by various governments and NGOs to raise awareness about the early diagnosis of microcalcifications in breast tissue.
For instance, the National Breast Cancer Screening
Programme in the Netherlands, for example, was created for women aged 50 to 75.
According to the program, women in this age bracket were invited for a
mammogram every two years. Similarly, in Australia, women aged 50 to 74 are
required to have free mammograms every 2 years as part of the government's
national screening program, Breast Screen Australia. Some other significant
organizations such as the National Breast Cancer Foundation, CDC, and Breast
Cancer Organization are promoting early diagnosis of mammary gland
calcification. This is one of the crucial factors expected to drive market
growth.
Major mammography manufacturers are introducing new
products and increasing the number of approved products, which is further
expected to impel the demand in the coming years. For instance, in March 2018,
Siemens Healthineers obtained U.S. FDA approval for its enhanced mammography
platform MAMMOMAT Revelation. This platform is combined with a new InSpect
specimen imaging tool as well as new HD Breast Biopsy technology for one-click
targeting of affected areas. Moreover, in October 2021, iCAD, Inc. launched its
latest generation of ProFound AI for 2D Mammography.
Furthermore, the use of Artificial Intelligence (AI)
in 3D mammography has reduced exam time while maintaining image quality. For
instance, in March 2021, iCad received USFDA approval for its ProFound AI
Version 3.0 for Digital Breast Tomosynthesis (DBT) system. Compared to previous
versions of the software, it provides up to a 10% enhancement in specificity
performance, up to 1% improvement in sensitivity, and offers 40% faster
processing. Thus, rapid FDA approval for AI-enabled 3D mammography equipment is
driving market growth.
Related Press Release@ Mammography Market Report
Mammography Market Report
Highlights
- Digital systems dominated the product segment in 2021 owing to the
wide availability of digital breast screening devices and the presence of
favorable reimbursements for such devices
- Digital mammography dominated the technology segment in 2021 due to
growing awareness regarding digital technology and increasing adoption of
such technology for better diagnosis
- In 2021, North America dominated due to the increasing adoption of
technologically advanced screening devices and the upsurging number of
approvals of 3D systems
- Asia Pacific and Latin America are the two fastest-growing regional
segments, because of the higher mammary gland cancer prevalence and the
growing number of government campaigns to improve breast screening
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment